In a press release, the Ministry of Health stressed that this drug is manufactured locally under its strict control, to ensure availability in sufficient quantities.

The stock of essential medicines is controlled weekly by the National Observatory for Medicine and Health Products (ONMPS), which is part of the Directorate of Medicine and Pharmacy (DMP), said the ministry.

It added that "Sintrom 4 mg" is distributed by industrial pharmaceutical establishments to all pharmacies in the Kingdom, in coordination with the DMP and under its strict control.

The ministry condemned the publication of such information, which undermine the country's reputation and its health system and denigrates efforts to ensure the normal functioning of the various health establishments.